Sanofi will work with the Biomedical Advanced Research and Development Authority to retrofit vaccine manufacturing facilities in Swiftwater, Pa. The effort will double Sanofi’s capacity to manufacture a recombinant protein-based flu shot.
The agreement gives HHS access to the drugmaker’s vaccine production capacity for up to 25 years, which translates into nearly 1 million flu shot doses for use during a pandemic.
Sanofi is the only drugmaker licensed to manufacture a recombinant flu shot in the U.S., which is much quicker to produce than traditional egg-based vaccines.
More articles on clinical leadership & infection control:
Mount Sinai’s ED is a ‘war zone,’ nurse says
Dallas children’s hospital relocates 28 patients after mold discovery
Police raid Georgia psych hospital over abuse allegations
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
